Adjunctive lamotrigine XR for primary generalized tonic–clonic seizures in a randomized, placebo-controlled study-Reference-Cited by-同舟云学术

Adjunctive lamotrigine XR for primary generalized tonic–clonic seizures in a randomized, placebo-controlled study

Published:2010-11 Issue:3 Volume:19 Page:352-358
ISSN:1525-5050
Container-title:Epilepsy & Behavior
language:en
Short-container-title:Epilepsy & Behavior

Author:

Biton Victor,Di Memmo Juan,Shukla Rakesh,Lee Yeong Yeh,Poverennova Irina,Demchenko Vladislav,Saiers Jane,Adams Bryan,Hammer Anne,Vuong Alain,Messenheimer John

Publisher

Elsevier BV

Subject

Behavioral Neuroscience,Neurology (clinical),Neurology

Reference31 articles.

1. LAMICTAL® (lamotrigine) prescribing information,2006

2. Steady-state pharmacokinetics of lamotrigine when converting from a twice-daily immediate-release to a once-daily extended-release formulation in subjects with epilepsy (The COMPASS Study);Tompson;Epilepsia,2008

3. Lamotrigine extended-release as adjunctive therapy for partial seizures;Naritoku;Neurology,2007

4. A systematic review of the associations between dose regimens and medication compliance;Claxton;Clin Ther,2001

5. Dose frequency and dose interval compliance with multiple antiepileptic medications during a controlled clinical trial;Cramer;Epilepsia,1995

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Demonstration of Group-Level and Individual-Level Efficacy Using Time-to-Event Designs for Clinical Trials of Antiseizure Medications;Neurology;2024-08-27

2. Lamotrigine add-on therapy for drug-resistant focal epilepsy;Cochrane Database of Systematic Reviews;2023-12-11

3. Efficacy and Safety of Five Broad-Spectrum Antiseizure Medications for Adjunctive Treatment of Refractory Epilepsy: A Systematic Review and Network Meta-analysis;CNS Drugs;2023-08-17

4. Antiseizure medications for idiopathic generalized epilepsies: a systematic review and network meta-analysis;Journal of Neurology;2023-06-28

5. Time‐to‐event clinical trial designs: Existing evidence and remaining concerns;Epilepsia;2023-05-02